- Tan DS, Kaye S. Ovarian clear cell adenocarcinoma: a continuing enigma. J Clin Pathol 2007;60 (4): 355–360.
- Matsuura Y, Robertson G, Marsden DE, Kim SN, Gebski V, Hacker NF. Thromboembolic complications in patients with clear cell carcinoma of the ovary. Gynecol Oncol 2007;104 (2): 406–410.
- Tavasolli FA, Devilee P. World Health Organization classification of tumors. Tumors of the breast and the female genital organs. Lyon, France: IARC Press, 2003: 8–12.
- Behbakht K, Randall TC, Benjamin I, Morgan MA, King S, Rubin SC. Clinical characteristics of clear cell carcinoma of the ovary. Gynecol Oncol 1998;70 (2): 255–258.
- del Carmen MG, Birrer M, Schorge JO. Clear cell carcinoma of the ovary: a review of the literature. Gynecol Oncol 2012;126 (3): 481–490.
- Lee YY, Kim TJ, Kim MJ, Kim HJ, Song T, Kim MK, Choi CH, Lee JW, Bae DS, Kim BG. Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis. Gynecol Oncol 2011;122 (3): 541–547.
- LaGrenade A, Silverberg SG. Ovarian tumors associated with atypical endometriosis. Hum Pathol 1988;19 (9): 1080–1084.
- Czernobilsky B, Morris WJ. A histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes. Obstet Gynecol 1979;53 (3): 318–323.
- Duska LR, Garrett L, Henretta M, Ferriss JS, Lee L, Horowitz N. When ‘never-events’ occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes. Gynecol Oncol 2010;116 (3): 374–377.
- Eltabbakh GH, Mount SL, Beatty B, Simmons-Arnold L, Cooper K. Clinical and molecular differences between clear cell and papillary serous ovarian carcinoma. J Surg Oncol 2006;93 (5): 379–386.
- Trousseau A. Phlegmasia Alba Dolens. Clinique Medicale del'Hotel-Dieu de Paris, 3. London: New Sydenham Society, 1865: 94.
- Sallah S, Wan JY, Nguyen NP. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost 2002;87 (4): 575–579.
- Goodnight SH Jr. Bleeding and intravascular clotting in malignancy: a review. Ann N Y Acad Sci 1974;230: 271–288.
- Gore M, Miller KE, Soong SJ, Clarke-Pearson DL, Pizzo SV. Vascular plasminogen activator levels and thromboembolic disease in patients with gynecologic malignancies. Am J Obstet Gynecol 1984;149 (8): 830–834.
- Crandon AJ, Koutts J. Incidence of postoperative deep vein thrombosis in gynaecological oncology. Aust N Z J Obstet Gynaecol 1983;23 (4): 216–219.
- Kroegel C, Reissig A. Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis. Respiration 2003;70 (1): 7–30.
- Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 2008;28 (3): 370–372.
- Esmon CT. Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev 2009;23 (5): 225–229.
- Previtali E, Bucciarelli P, Passamonti SM, Martinelli I. Risk factors for venous and arterial thrombosis. Blood Transfus 2011;9 (2): 120–138.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 27, 2014 - Issue 4